Nordea Investment Management AB Has $10.54 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Posted by on Jul 3rd, 2023

Nordea Investment Management AB lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 512.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 130,677 shares of the company’s stock after purchasing an additional 109,353 shares during the period. Nordea Investment Management AB owned 0.10% of Henry Schein worth $10,539,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of HSIC. Dupont Capital Management Corp increased its position in Henry Schein by 73.9% during the fourth quarter. Dupont Capital Management Corp now owns 546 shares of the company’s stock worth $44,000 after buying an additional 232 shares during the last quarter. Allworth Financial LP increased its holdings in shares of Henry Schein by 3,594.1% during the 1st quarter. Allworth Financial LP now owns 628 shares of the company’s stock worth $51,000 after acquiring an additional 611 shares during the last quarter. Godsey & Gibb Inc. bought a new stake in Henry Schein in the 4th quarter valued at $64,000. ANTIPODES PARTNERS Ltd acquired a new stake in Henry Schein during the 4th quarter valued at $65,000. Finally, Covestor Ltd boosted its position in Henry Schein by 88.4% during the first quarter. Covestor Ltd now owns 861 shares of the company’s stock worth $75,000 after purchasing an additional 404 shares during the period. 94.75% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Henry Schein news, Vice Chairman James P. Breslawski sold 24,234 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $74.29, for a total transaction of $1,800,343.86. Following the transaction, the insider now owns 201,555 shares in the company, valued at approximately $14,973,520.95. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other Henry Schein news, Vice Chairman James P. Breslawski sold 24,234 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $74.29, for a total transaction of $1,800,343.86. Following the transaction, the insider now owns 201,555 shares in the company, valued at approximately $14,973,520.95. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Mark E. Mlotek sold 24,747 shares of the firm’s stock in a transaction on Friday, May 19th. The stock was sold at an average price of $76.68, for a total value of $1,897,599.96. Following the transaction, the executive vice president now owns 69,138 shares in the company, valued at approximately $5,301,501.84. The disclosure for this sale can be found here. Insiders have sold a total of 75,019 shares of company stock worth $5,651,018 in the last 90 days. Company insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $81.10 on Monday. The stock has a market cap of $10.62 billion, a P/E ratio of 23.17, a PEG ratio of 2.27 and a beta of 0.83. The stock has a 50 day simple moving average of $77.71 and a 200 day simple moving average of $80.27. The company has a current ratio of 1.82, a quick ratio of 0.94 and a debt-to-equity ratio of 0.25. Henry Schein, Inc. has a 1-year low of $64.75 and a 1-year high of $89.72.

Henry Schein (NASDAQ:HSIC – Free Report) last released its quarterly earnings results on Tuesday, May 9th. The company reported $1.21 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.02). The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.09 billion. Henry Schein had a return on equity of 15.41% and a net margin of 3.82%. The business’s revenue for the quarter was down 3.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.30 earnings per share. Research analysts anticipate that Henry Schein, Inc. will post 5.26 earnings per share for the current year.

Analysts Set New Price Targets

HSIC has been the topic of several research analyst reports. Barrington Research dropped their price objective on shares of Henry Schein from $92.00 to $90.00 in a research report on Wednesday, May 10th. UBS Group raised their price objective on shares of Henry Schein from $75.00 to $82.00 and gave the stock a “neutral” rating in a research report on Tuesday, March 7th. Finally, StockNews.com downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $86.14.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.